ALKEMNSEAlkem Laboratories Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 29 Dec, 2025 · 15:02 IST

Alkem Labs receives GST demand orders from Haryana and Rajasthan authorities

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.0%Reaction day
₹5537.00
prior close
₹5509.50
announcement price
In-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.4%-0.6% vs market
Pharmaceuticals peers, median of 153sector-0.8%-0.2% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Midcap 150 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
-0.1
15m
-0.1
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.0-0.4-0.6-0.8-0.2
Next day
-1.9-0.6-1.3-1.0-0.9
2d
-1.2+0.4-1.6-0.1-1.1
3d
-1.3+0.8-2.1-0.2-1.1
4d
+0.9+1.7-0.9+0.7+0.2
5d
+0.6+1.6-1.1+0.3+0.3
1w
+4.6+1.9+2.7+1.6+3.0
15d
+2.4-3.9+6.3-5.9+8.4
1m
+3.2-3.2+6.4-7.8+10.9
2m
+0.8-3.2+4.0-8.6+9.4
3m
-4.3-12.4+8.2-16.7+12.4
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Labs received two GST demand orders totaling about Rs 2.14 crore (tax plus penalty). Haryana authority for FY 2021-22 demands Rs 1.83 crore tax and Rs 18.31 lakh penalty. Rajasthan authority for FY 2018-19 demands Rs 6.12 lakh tax and Rs 6.12 lakh penalty. Both allege excess Input Tax Credit claims. The company plans to appeal and says there is no material financial impact.

Likely market impact

Minor: total demand about Rs 2.14 crore is small relative to company size. Company will appeal; no material financial impact disclosed.